Sofia Michael J. has filed 5 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 109500 shares of Arbutus Biopharma Corp ($ABUS) on February 01, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | Sofia Michael J. | Chief Scientific Officer | A | Common Shares | 109500 | $0.00 | 1,662,265.0000 | 0 | 7.05% | 0.00% |
| Feb. 2, 2024 | Arbutus Biopharma Corp | $ABUS | Sofia Michael J. | Chief Scientific Officer | S | Common Shares | 9982 | $2.31 | 1,652,283.0000 | 0 | 0.60% | 0.00% |
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | Sofia Michael J. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 437800 | $0.00 | 437,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Arbutus Biopharma Corp | $ABUS | Sofia Michael J. | Chief Scientific Officer | A | Common Shares | 82200 | $0.00 | 1,552,765.0000 | 0 | 5.59% | 0.00% |
| Feb. 1, 2023 | Arbutus Biopharma Corp | $ABUS | Sofia Michael J. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 328700 | $0.00 | 328,700.0000 | 0 | 9999.99% | 0.00% |